LEADER 01699nam  2200553   450 
001 9910463608003321
005 20200520144314.0
010   $a1-938835-56-5
035   $a(CKB)2670000000577717
035   $a(OCoLC)900888950
035   $a(CaPaEBR)ebrary10989985
035   $a(SSID)ssj0001382427
035   $a(PQKBManifestationID)12591406
035   $a(PQKBTitleCode)TC0001382427
035   $a(PQKBWorkID)11458712
035   $a(PQKB)10125585
035   $a(MiAaPQ)EBC3383955
035   $a(Au-PeEL)EBL3383955
035   $a(CaPaEBR)ebr10989985
035   $a(CaONFJC)MIL664466
035   $a(EXLCZ)992670000000577717
100   $a20141217h20142014  uy             0
101 0 $aeng
135   $aurcnu||||||||
181   $ctxt
182   $cc
183   $acr
200 10$aBusiness administration for clinical trials $emanaging research, strategy, finance, regulation, and quality /$fR. Jennifer Cavalieri, Mark E. Rupp
210  1$aIndianapolis, Indiana :$cSigma Theta Tau International,$d2014.
210  4$dİ2014
215   $a1 online resource (304 p.) 
300   $aIncludes index.
311   $a1-938835-54-9 
311   $a1-322-33184-7 
606   $aClinical medicine$xPractice
606   $aMedical offices$xManagement
608   $aElectronic books.
615  0$aClinical medicine$xPractice.
615  0$aMedical offices$xManagement.
676   $a610.72/4068
700   $aCavalieri$b R. Jennifer$0929047
702   $aRupp$b Mark E.
801  0$bMiAaPQ
801  1$bMiAaPQ
801  2$bMiAaPQ
906   $aBOOK
912   $a9910463608003321
996   $aBusiness administration for clinical trials$92087933
997   $aUNINA